Back to results
CompletedN/A

Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM

NCT06492330

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Dep.endocrinology of Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

View on ClinicalTrials.gov
Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM — TrialFind